Last update 01 Nov 2024

TTR x KLKB1 x Hemoglobins

Basic Info

Related Targets
TTRKLKB1Hemoglobins

Related

1
Drugs associated with TTR x KLKB1 x Hemoglobins
BEAM-101
Target
Hemoglobins x KLKB1 x TTR
Mechanism
Hemoglobins stimulants [+2]
Active Org.
Beam Therapeutics, Inc.Beam Therapeutics, Inc.
Originator Org.
Beam Therapeutics, Inc.Beam Therapeutics, Inc.
Active Indication
Beta-Thalassemia [+2]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with TTR x KLKB1 x Hemoglobins
NCT05456880 / RecruitingPhase 1/2
A Phase 1/2 Study Evaluating the Safety and Efficacy of a Single Dose of Autologous CD34+ Base Edited Hematopoietic Stem Cells (BEAM-101) in Patients With Sickle Cell Disease and Severe Vaso-Occlusive Crises (Beacon Trial)
100 Clinical Results associated with TTR x KLKB1 x Hemoglobins
Login to view more data
100 Translational Medicine associated with TTR x KLKB1 x Hemoglobins
Login to view more data
0 Patents (Medical) associated with TTR x KLKB1 x Hemoglobins
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free